Paul Mahon Sells 11,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock
MarketBeat
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) EVP Paul Mahon sold 11,000 shares of United Therapeutics stock in a transaction on Thursday, October 16th. The stock was sold at an average price of $431.50, for a total transaction of $4,746,500.00. Following the completion of the transaction, the executive vice president directly owned 36,781 shares of the company's stock, valued at $15,871,001.50. The trade was a 23.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
NASDAQ:UTHR